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Abstract
Background:  The heritability of cardiovascular risk factors is expected to differ between
populations because of the different distribution of environmental risk factors, as well as the genetic
make-up of different human populations.
Methods: The purpose of this analysis was to evaluate genetic and environmental influences on
cardiovascular risk factor traits, using a variance component approach, by estimating the heritability
of these traits in a sample of 1,666 individuals in 81 families ascertained randomly from a highly
admixed population of a city in a rural area in Brazil.
Results: Before adjustment for sex, age, age2, and age × sex interaction, polygenic heritability of
systolic (SBP) and diastolic (DBP) blood pressure were 15.0% and 16.4%, waist circumference
26.1%, triglycerides 25.7%, fasting glucose 32.8%, HDL-c 31.2%, total cholesterol 28.6%, LDL-c
26.3%, BMI 39.1%. Adjustment for covariates increased polygenic heritability estimates for all traits
mainly systolic and diastolic blood pressure (25.9 and 26.2%, respectively), waist circumference
(40.1%), and BMI (51.0%).
Conclusion: Heritability estimates for cardiovascular traits in the Brazilian population are high and
not significantly different from other studied worldwide populations. Mapping efforts to identify
genetic loci associated with variability of these traits are warranted.
Background
The etiology of cardiovascular disease is complex and it is
thought to involve metabolic, neuro-endocrine and
genetic interactions [1-4]. Prospective twin studies [5],
familial aggregation [6] and intercorrelation analyses [7]
have supported the existence of significant genetic influ-
ence modulating inter-individual variability for cardiovas-
cular related traits. However, results of genetic
epidemiological studies have been inconsistent, and it is
unknown whether the genetic effect occurs through a
major locus [4,8] or multiple [2,4] distinct loci acting in
concert, but with relatively small effects.
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The heritability of cardiovascular risk factors is expected to
differ between populations because of the different distri-
bution of environmental risk factors, as well as the partic-
ular genetic make-up of different human populations.
Because of the high prevalence of cardiovascular disease
and its risk factors, many studies have been conducted in
populations worldwide to estimate their heritability.
These studies have presented conflicting results probably
due to different populations being used to derive these
inferences (3, 4), such as populations with high preva-
lence of cardiovascular disease (16,18), diabetes (7) and
obesity (7), or healthy populations (12,13,25). Thus, the
purpose of this study was to evaluate genetic and environ-
mental influences on cardiovascular risk factor traits,
using a variance component approach, by estimating the
heritability of these traits in a sample of extended pedi-
grees ascertained from a highly admixed population of a
rural city in Brazil.
Methods
Study population and sample design
Between December 2005 and January 2006, 119 families
(1,712 individuals) were selected in Baependi, a city in a
rural area (752 Km2, 18,072 inhabitants) located in Minas
Gerais State, Brazil. Probands were identified from the
community at large in several stages. First, eleven census
districts (from a total of twelve) were selected for study.
Second, residential addresses within each district were
randomly selected (first by randomly selecting a street,
second a household). Finally, eligibility criteria (any indi-
vidual living in the selected household who was 18 years
old or above) within each household were established.
Once a proband was enrolled, all his/her first-degree (eg,
parents, siblings, and offspring), second-degree (eg, half-
siblings, grandparents/grandchildren, aunts/uncles,
nieces/nephews, and double cousins), and third-degree
(eg, first cousins, great-uncles/great-aunts, and great-
nephews/great-nieces) relatives and his/her respective
spouse's relatives, who were at least 18 years old, were
invited to participate. After the proband's first contact,
first degree relatives were invited to participate by phone;
these included all living relatives in the city of Baependi
(urban and rural area) and surrounding cities. To recruit
the participants, the project was advertised through pro-
vincial, religious, and municipal authorities, in local tele-
vision, newspaper, and radio messages, through
physicians, and by phone calls. For physical examination,
a clinic was established in a quiet but easily accessible sec-
tor of Baependi. Only individuals age 18 and older were
eligible to participate in the study.
Trait description
A questionnaire was administered to each participant to
obtain information on family relationships, demographic
characteristics, medical history, and environmental risk
factors such as smoking habit, alcohol use, physical activ-
ity, and prescription drug use (e.g., anti-hypertensive, for
diabetes, for dyslipidemia). Questionnaire was adminis-
tered and filled out by research assistants specially trained
for this task. The questionnaire was based on the WHO-
MONICA epidemiological instrument and was previously
used by our group in other epidemiological projects
[9,10].
Anthropometric measures such as weight, body height
and waist circumference were measured following stand-
ardized procedures. Height was measured in centimeters
and weight in kilograms using a calibrated digital balance.
Body mass index (BMI) (weight in Kg/height in meters2)
was calculated and overweight defined as BMI ? 25 Kg/m2
or obesity, BMI ? 30 Kg/m2. Waist circumference (WC)
was measured half way between the lowest rib and the
iliac crest while the subject was at minimal respiration. An
individual was considered sedentary who worked seated
or did not walk during work and who did not have any
physical activity during leisure time. Smoking status was
defined as "current smoker" when smoking has occurred
during the last six months. Blood pressure was measured
using a standard digital sphygmomanometer (OMRON,
Brazil) on the left arm after 5 minutes rest, in the sitting
position. Systolic and diastolic blood pressures were cal-
culated from three readings (mean value of all measure-
ments), with a minimal interval of 3 minutes. Physical
examination and electrocardiogram were performed con-
currently by trained medical students.
Fasting blood glucose, total cholesterol, lipoprotein frac-
tions, and triglycerides were assayed by standard tech-
niques in 12 hour fasting blood samples. Serum samples
were stored at -80°C and genomic DNA was extracted fol-
lowing a standard salting-out procedure.
The study protocol was approved by the ethics committee
of the Hospital das Clinicas, University of Sao Paulo, Brazil,
and each subject provided informed written consent
before participation.
Statistical Analysis
Descriptive statistics were calculated to describe familial
structure of the Baependi data set. In addition, descriptive
measures, such as mean, median, standard deviation,
skewness and kurtosis, were calculated for all traits con-
sidering the total sample and gender stratification. When
the normality assumption did not hold for a specific trait,
natural log-transformation was applied followed by a new
data assessment. After the trait transformations, when the
residual kurtosis remained too high we tried to prevent
biased heritability estimates using robust estimation
implemented in SOLAR through the tdist procedure.BMC Medical Genetics 2008, 9:32 http://www.biomedcentral.com/1471-2350/9/32
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Polygenic heritability estimates were calculated, adjusted
for age, gender and medication use, for each cardiovascu-
lar related trait, using the variance-components approach
implemented in the SOLAR package [11]. Heritability was
calculated as the proportion of the total phenotypic vari-
ance explained by additive genetic effects after accounting
for covariates.
The overall aim of these analyses was to determine the
extent to which unmeasured genetic factors, and meas-
ured environmental and lifestyle factors, contributed to
variation in a large panel of cardiovascular-related traits.
Information on the covariance among relatives was used
to estimate the polygenic (or additive genetic) component
of variance. The variance component model is a well-
known tool for heritability estimates in family studies and
is only briefly described here [11,12]. Under this model,
the level of the trait for individual I (denoted by yi) is
described as follows:
where ? is the general mean of the trait, and ?j is the regres-
sion coefficient for covariate j, which assumes the value Xij
for individual i. Measures of the qualitative covariates (eg,
female gender, diabetes, medication use, etc.) were scaled
so that the regression coefficient represents the effect of
having the covariate present compared with having it
absent. The remaining parameters, gi and ei are the resid-
ual genetic effect due the polygenic term, and random
error component, respectively. The random effects, gi and
ei are assumed to be uncorrelated and normally distrib-
uted with mean zero and variance   and   respec-
tively. As usual, the error component is unique to each
individual, whereas the polygenic component is shared
between individuals in proportion to their kinship coeffi-
cient. Thus, the covariance between traits for individuals i
and i' is given by:
Parameter 2?ii is the coefficient of relationship between
individuals i and i'. The likelihood of the traits of family
members is assumed to follow a multivariate normal dis-
tribution. Estimates of the mean and variance compo-
nents are obtained using maximum likelihood methods.
Firstly the variance component model was fitted without
any covariate effects, denoted by unadjusted model
(Model 1). Secondly two sets of covariate effects on each
traits were considered: under Model 2 the covariates were
sex, age, age2, and sex × age interaction; under Model 3,
besides the covariates from Model 2, current medication
use was also considered. The likelihood ratio test (LRT)
was applied to test whether the additive polygenic effect in
each analysis accounted for a significant component of
the variation for the trait under study, after adjusting for
the covariates. This test compares the likelihood of a full
model (covariates, and additive polygenic and residual
random components) with that of a nested model (cov-
ariates, and the residual component only). The LRT is
asymptotically distributed as a mixture of  , and
.
The inclusion of covariates in the variance component
model might influence the proportion of the phenotypic
variance associated with the polygenic effect. Increased
precision might be obtained if the heritability estimates
increase with the covariate adjustments in comparison to
the reduced or unadjusted model. But, when the heritabil-
ity estimates decrease with the covariate inclusion, it
means that the covariate explains a part of the familial
relationship associated to the polygenic effect.
Risk factors were analyzed both as continuous and cate-
gorical variables. Dichotomized traits were defined
according to the ATPIII criteria [13], as follows: truncal
obesity was diagnosed when waist was more than 102 cm
in men and more than 88 cm in women. High fasting glu-
cose was defined when glucose levels were ?110 mg/dL or
with current use of anti-diabetic medication. The defini-
tion of low HDL cholesterol was considered when levels
were < 40 mg/dL in men and < 50 mg/dL in women, high
triglycerides ? 150 mg/dL, high LDL-c ? 130 mg/dL, high
total cholesterol ? 200 mg/dL or use of lipid lowering
medication. Hypertension was defined as mean systolic
blood pressure of ? 140 mmHg and/or diastolic blood
pressure of ? 90 mmHg or the current use of anti-hyper-
tensive medication. Heritabilities for dichotomized traits
were also estimated under the variance component model
using SOLAR. Because the current medication informa-
tion was absorbed into the trait's dichotomization crite-
rion, Model 3 was not fitted to those traits.
Results
Descriptive statistics
We examined 1,712 individuals in 119 families, repre-
senting 13.5% of the entire city's population above 18
years. Because 38 of the ascertained families were com-
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posed of fewer than 3 individuals we have decided to use
the remaining 1,666 individuals in 81 families for the cur-
rent analysis. Family size varied from 3 to 156 individuals
with a mean of 21 subjects per family. Data from 631
nuclear families were available, with a size ranging from
one to 14 offspring. The number of generations per family
varied from 2 to 4. Fifty-four percent of the ascertained
families had 3 generations, and 45% of the families had 2
generations. The mean age was 44 years, with the range of
18 to 95 years. Women accounted for 56 percent of the
study subjects. Seventy-six (4.2%) subjects were on lipid-
lowering medications, 70 (4.0%) subjects were on
hypoglycemic medications, and 405 (24.3%) subjects
were on antihypertensive medications.
Mean fasting glucose, triglycerides, HDL-cholesterol,
waist circumference and systolic (SBP) and diastolic
(DBP) blood pressures are showed in Table 1. We
observed that the prevalence of high fasting glucose was
higher among women (20.9% female vs. 17.4% male).
The same was observed with high waist circumference
(45.1% female vs. 8.7% male), low HDL-cholesterol
(34.3% female vs. 16.9% male), high LDL-c (28.0%
female vs. 22.7% male), and high total cholesterol
(36.2% female vs. 32.3% male). Hypertension was preva-
lent among both women and men (38.0% female vs.
33.8% male). Overweight and obesity were predominant
among women, and this gender was more sedentary. For
high triglycerides (28.6% female vs. 28.9% male), the val-
ues were similar in both genders. These variables were
adjusted for the use of anti-diabetic and anti-hypertensive
medication.
Heritability estimates
Heritability estimates for cardiovascular risk factor traits
were all high, ranging from 26 to 51 percent (adjusted for
age, sex, age2, age × sex), and BMI was the highest (Table
2). All heritability estimates were highly significant (p <
0.0001). Waist circumference, fasting glucose, triglycer-
ides, LDL-cholesterol, BMI and systolic blood pressure
showed excessive skewness and kurtosis and were there-
fore log-transformed. After the trait transformations,
when the residual kurtosis remained too high the tdist
procedure implemented in SOLAR was used (Table 2).
We performed quantitative genetic analyses for each trait,
prior to and after adjustment for age, sex, age2, age × sex
interaction, and current medication. The heritability esti-
mates are shown in Table 2 and are expressed as the per-
centage of the total phenotypic variability due to the
polygenic component, before and after adjustment for
covariates. Before adjustment (Model 1), heritabilities of
systolic and diastolic blood pressure were 15% and
16.4%, waist circumference 26.1%, triglycerides 25.7%,
fasting glucose 32.8%, HDL-c 31.2%, TC 28.6%, LDL-c
26.3%, and BMI 39.1%. Adjustment for age, sex, age2, and
age × sex interaction (Model 2) increased heritability esti-
mates for all traits mainly SBP (25.9%), DBP (26.2%),
waist circumference (40.1%), and BMI (51.0%). When we
accounted for medication use (Model 3), heritability esti-
Table 1: Descriptive statistics of studied phenotypes, distributed by gender.
Total (n = 1,666) Men (n = 723) Women (n = 943)
Age (years) 44.0 (16.9) 44.7 (17.5) 43.6 (16.5)
Waist circumference (cm) 87.4 (12.5) 86.8 (11.6) 87.9 (13.1)
Fasting glucose (mg/dL) 93.7 (30.0) 93.1 (26.5) 94.2 (32.0)
Triglycerides (mg/dL) 133.3 (75.4) 134.8 (82.6) 132.2 (69.3)
HDL-c(mg/dL) 55.9 (15.6) 53.9 (15.3) 57.5 (15.7)
Total cholesterol (mg/dL) 180.8 (48.0) 176.7 (48.5) 183.9 (47.4)
LDL-c (mg/dL) 98.7 (44.1) 96.0 (43.8) 100.7 (44.2)
Systolic blood pressure (mmHg) 126.8 (19.4) 130.3 (18.7) 124.1 (19.4)
Diastolic blood pressure (mmHg) 78.8 (11.4) 79.4 (11.6) 78.3 (11.2)
BMI (kg/m2) 24.4 (4.8) 23.4 (3.8) 25.2 (5.3)
High Fasting glucose(%) 19.4 17.4 20.9
High blood pressure (%) 36.2 33.8 38.0
Truncal obesity (%) 29.3 8.7 45.1
High Triglycerides (%) 31.1 30.6 31.5
Low HDL-c (%) 29.3 18.7 37.3
High LDL-c (mg/dL) 25.7 22.7 28.0
High TC (mg/dL) 34.5 32.3 36.2
BMI > 25 kg/m2 (%) 38.6 29.9 45.2
BMI > 30 kg/m2 (%) 12.7 6.4 17.5
Smokers (%) 16.6 20.6 13.5
Sedentarism (%) 21.1 17.8 23.7
Mean values and standard deviation for quantitative traits
Values for dichotomized traits are expressed in percentages.BMC Medical Genetics 2008, 9:32 http://www.biomedcentral.com/1471-2350/9/32
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mates were reduced for all traits apart from HDL-c, total
cholesterol, LDL-c and triglycerides.
When the cardiovascular risk factors were treated as
dichotomized traits, the estimates of heritability varied
from 25.5 for high triglycerides to 54.5 percent for high
fasting glucose after adjusting for covariates. (Table 3)
Discussion
The Baependi Heart Study provides an exceptional oppor-
tunity to characterize the genetic contributions to cardio-
vascular risk factors in a highly admixed population such
as the Brazilian population. In this study we evaluated
1,666 individuals in 81 families to estimate the heritabil-
ity of cardiovascular risk factors. These values were high,
and varied from 26% (SBP and DBP) to 51% (BMI).
Although cardiovascular risk factors have been defini-
tively demonstrated to be heritable, the heritability esti-
mates of traits such as blood pressure levels, fasting
glucose, lipids and obesity (3,4,7) are largely variable
among populations and are dependent on the inclusion
criteria used in a particular study (3,4). Nevertheless,
despite these operational limitations, heritability attrib-
uted to cardiovascular risk factor traits is significant in
most studies reported to date.
In this study the estimation of the genetic component of
variance was limited to that attributable to polygenic
effects and probably results from actions of more than one
gene. If other nonadditive sources of genetic variation are
considered, such as dominance or epistasis, then these
observed heritabilities will represent lower bounds.
Conducting gene mapping studies in admixtured popula-
tions might be advantageous secondary to the possibility
of finding genetic markers associated with a particular
trait in a smaller linkage disequilibrium block. In this sce-
nario fine-mapping of QTLs may prove to be more suc-
cessful then identifying genetic determinants in
populations were LD blocks span a significantly higher
genomic interval.
It is difficult to compare our data with those from previ-
ous studies. The majority of studies were conducted in
specific populations with different a priori risk for cardio-
vascular disease. The Framingham Heart Study was con-
ducted in the general population, but blood glucose
measurements were conducted in non-fasting samples. In
addition, mean age was higher than the one observed in
our population and only individuals 30 years old or
higher were evaluated. In this study the observed herita-
bility was high: systolic blood pressure (48%), fasting glu-
cose (39%), triglycerides (56%), HDL-c (62%), and BMI
(51%) [3]. The San Antonio Family Heart Study was
designed to investigate the genetics of heart disease and its
risk factors in Mexican Americans which are considered a
high risk population because of the unusually high diabe-
tes prevalence. In agreement with our estimates, heritabil-
ity values as high as 46% of HDL-c variance, 42% of BMI
variance, 40% of triglycerides variance, and 18% of systo-
Table 2: Heritability (h2) estimates, and standard error, for each quantitative trait for cardiovascular risk factors (in percentage), 
unadjusted (Model 1), adjusted for age, sex, age2, and age × sex interaction (Model 2), and adjusted for age, sex, age2, and age × sex 
interaction, and current medication (Model 3).
Model 1* Model 2* Model 3*
Waist circumference (cm) 26.1(0.042) 40.1(0.049) -
Fasting glucose (mg/dL)? 32.8(0.046) 34.5(0.047) 32.3(0.047)
Triglycerides (mg/dL) 25.7(0.044) 28.8(0.048) 28.4(0.048)
HDL-cholesterol (mg/dL) 31.2(0.045) 32.0(0.046) 32.3(0.046)
Systolic blood pressure (mmHg)? 15.0(0.036) 25.9(0.042) 20.6(0.042)
Diastolic blood pressure (mmHg)? 16.4(0.037) 26.2(0.044) 21.0(0.044)
Total Cholesterol (mg/dL)? 28.6(0.047) 29.2(0.049) 30.4(0.049)
LDL-cholesterol (mg/dL)? 26.3(0.048) 26.3(0.049) 27.2(0.050)
BMI (kg/m2) 39.1(0.045) 51.0(0.048) -
* p-value < 0.0001
? using tdist procedure in SOLAR
Table 3: Heritability (h2) estimates, and standard error, for 
cardiovascular risk factors treated as dichotomized traits, 
unadjusted (Model 1) or adjusted for age, sex, age2, and age × 
sex interaction (Model 2).
Model 1 Model 2
Truncal obesity 25.44* 40.59*
High fasting glucose 45.90* 54.52*
High triglycerides 24.03* 25.50*
Low HDL-cholesterol 31.69* 37.79*
High Total-cholesterol 37.33* 38.08*
High LDL-cholesterol 37.09* 37.10*
Hypertension 13.24 (p = 0.0006) 32.49*
*p-value < 0.0001BMC Medical Genetics 2008, 9:32 http://www.biomedcentral.com/1471-2350/9/32
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lic blood pressure and fasting glucose variance were
observed [14]. The Northern Manhattan Family Study is a
cohort of high risk Caribbean-Hispanic probands, in
which inclusion criteria were defined by one of the fol-
lowing: reporting a sibling with a history of myocardial
infarction or stroke; or having two of three quantitative
risk phenotypes (maximal carotid plaque thickness, left
ventricle mass divided by body surface area, or homo-
cysteine level) above the 75th percentile in the Northern
Manhattan Study. The results of this study also showed
high heritability for cardiovascular risk factors: HDL-c
(60%), triglycerides (47%), waist circumference (46%),
fasting glucose (24%), diastolic blood pressure (21%)
and systolic blood pressure (16%) [15]. The Kiel obesity
prevention study described heritabilities of 54% for trun-
cal obesity, 39% for HDL-c, 31% for fasting glucose and
triglycerides, 27% for DBP and 18% for SBP. The inclu-
sion criterion for this study was the presence of at least
one overweight or obese family member in a white North-
ern-European population [16].
It should be noted, however, that in spite of these caveats
the heritability estimates from the present study are in the
range of commonly reported heritability estimates from
other populations (Table 4).
Another potential problem in comparing the various stud-
ies is the different set of covariates used in each final
model. In addition, some studies excluded individuals
with vascular disease or diabetes mellitus [17,18].
In our data, heritability estimates increased for all traits
after adjustment for sex and age, and model adjustment
was particularly important for the final estimate for waist
circumference, SBP, DPB and BMI. Interestingly, for fast-
ing glucose, DBP, and SBP, unlike the results observed in
the adjustment for age and gender (Table 2, Model 2) we
observed an important reduction in the estimated herita-
bility when prior use of medication was included as a cov-
ariate in the model (Table 2, Model 3). This means that
medication use for those four traits contains information
about trait variability due to the polygenic component,
rather than to the error component. Such patterns of effect
suggest that, in our population, the current use of anti-
hypertensive and anti-diabetic medications, but not the
use of lipid lowering medication, is associated with the
estimated heritability and, consequently, with genetic
determinants. In fact, the relationship between covariates
and variance components spaces have been explored in
linkage studies [19]. One possible explanation for this fact
is that being on treatment is a marker for unusual values
of the trait, and hence explains some of the genetic varia-
tion.
There are potential shortcomings and limitations that
must be considered when generalizing about our findings.
Firstly, we only used a single measurement in time for the
present analysis. It is possible that several cardiovascular
risk measurements taken over time may provide addi-
tional information and represent more stable estimates.
In fact, this has been shown for long-term blood pressure
heritability estimates [20], and may indeed have a more
pronounced effect for other measured traits that are noto-
riously variable (for example; triglycerides). In addition,
our results for the dichotomized traits are limited in at
least two ways. First, it is known that the dichotomization
of continuous variables result in loss of information. Sec-
ond, the results obtained are intrinsically dependent on
the cut-off values adopted in our analysis. In particular,
this may have a profound impact on the estimates of waist
circumference and low-HDL cholesterol that use cut-off
values that were operationally determined for the meta-
bolic syndrome diagnosis and established mainly in Cau-
casian populations [4,16,21]. It should be noted,
however, that different proposals for these cut-off values
do exist and vary between different diagnostic criteria [22-
24], different populations [4,15-18,21,25-31] and differ-
ent genders [28,32]. Clearly, using alternative cut offs
would lead to different heritability estimates and this
point should be better explored in future studies. Never-
theless, we believe obtaining heritability estimates for
clinically used dichotomized traits is important for study
comparison and future mapping efforts and algorithm
construction. Finally, one can not differentiate common
environmental from pure genetic factors in this study.
Familial aggregation of cardiovascular risk factors has
complex interactions among genes and environmental
factors.
Conclusion
Taken together, we provide the first evidence that a signif-
icant proportion of the variability of cardiovascular risk
factors is explained by genetic factors in this large sample
of a Brazilian population. Further studies of genetic link-
age and candidate gene association are warranted to iden-
tify specific genetic variants associated with these
important predictors of cardiovascular disease events and
mortality.
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Table 4: Cardiovascular risk factor heritability estimates (percentage) in different studies.
Studied population Number of 
Individuals 
Studied
Number of 
ascertaine
d Families
Waist 
circumference
Fasting glucose Triglycerides HDL-c Total 
Cholesterol
LDL-c Systolic blood 
pressure
Diastolic blood 
Pressure
Body Mass Index
Northern 
Manhattan Family 
Study [16]
Caribbean-hispanic. High 
cardiovascular risk 
individuals
803 89 46.0 24.0 47.0 60 16.0 21.0
Covariates Gender age Gender, age, 
hypoglice mic 
drug
Gender, age, 
hypolipidemic 
drug
Gender, age, 
hypolipide mic 
drug
Gender, age, 
anti-
hypertensive 
medication
Gender, age, 
anti-
hypertensive 
medication
San Antonio 
Family Heart 
Study [14]
Mexican-american 
individuals. High 
cardiovascular risk 
individuals
950 42 5.8 (WHR) 18.0 40.0 46.0 18.0 42.0
Covariates Gender, age, age2, 
diabetes, diabetes 
duration, total 
dietary 
cholesterol ntake, 
menopausal status
Gender, age, 
age2, total 
protein.
Gender, age, age2, 
diabetes, 
polyunsaturated/
sat rated fat 
intake, oral 
contraceptive use
Gender, total 
alcohol 
consuption, 
smoking status, 
postmenopausal 
estrogen use
Gender, age, 
age2, oral 
contraceptive 
use
Gender, age, age 
2, menopausal 
status
Gender, age, 
age2, diabetes, 
caloric intake
Gender, age, 
age2, diabetes
Gender, age, age2, 
diabetes, diabetes 
duration, total 
dietary cholesterol 
intake,
Community-
based study of 
healthy families 
[18]
Healthy individuals, 
northern European 
ethnicity
537 89 21.0 19.0 44.0 33.0 19.0 37.0
Covariates Gender, age Gender, age Gender, age Gender, age Gender, age Gender, age
Chin-Shan 
community family 
study [26]
Chinese individuals. 
General population, 
mainly young individuals
1356 - 17.0 27.2 26.7 29.9 32.8 40.1 32.1 23.2 21.6
Covariates Not informed
The Kiel obesity 
prevention study 
[16]
Northern European 
Caucasian with at least 
one overweight or 
obese individual in the 
family
492 86 54.0 31.0 31.0 39.0 18.0 27.0
Covariates Gender, age Gender, age Gender, age Gender, age Gender, age Gender, age
Framingham 
Heart Study [3]
General population 1617 - 39.0 (non-
fasting)
56.0 62.0 48.0 51.0
Covariates Gender, age Gender, age Gender, age Gender, age Gender, age
Strong Heart 
Family Study 
[20]
Native american 
individuals. High 
cardiovascular risk 
individuals
950 32 29.0 40.0 50.0 23.0 34.0 44.0
Covariates Gender, age, 
alchool 
consuption, 
estrogen use
Gender × age Gender, age, 
alcohol 
consuption, 
estrogen use
Gender, age, 
gender × age
Gender, age, 
alcohol 
consuption, 
estrogen use
Baependi 
Heart Study
Brazilian individuals. 
General population
1666 81 40.1 34.5 28.8 32.0 29.2 26.3 25.9 26.2 51.0
Covariates Gender, age, age2, 
gender × age
Gender, age, 
age2, gender × 
age
Gender, age, age2, 
gender × age
Gender, age, age2, 
gender × age
Gender, age, 
age2, gender × 
age
Gender, age, 
age2, gender × 
age
Gender, age, 
age2, gender × 
age
Gender, age, 
age2, gender × 
age
Gender, age, age2, 
gender × ageBMC Medical Genetics 2008, 9:32 http://www.biomedcentral.com/1471-2350/9/32
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